Lifestyle
- Regular physical activity
- Weight management
- Stress reduction
- Adequate sleep
Fasting Insulin · Insulin nüchtern
Fasting insulin quantifies the concentration of insulin in the blood after an overnight fast.
Ranges may vary slightly by laboratory; fasting is required for accurate assessment.
Fasting insulin, also known as Nüchterninsulin, is a biomarker that measures the level of insulin in the blood after an overnight fast. Insulin is a hormone produced by the pancreas that regulates glucose levels by facilitating the uptake of glucose into cells. This test is crucial for assessing insulin sensitivity and pancreatic β-cell function. Clinically, fasting insulin is significant in diagnosing and managing conditions like type 2 diabetes, metabolic syndrome, and polycystic ovary syndrome (PCOS). Elevated fasting insulin levels are often indicative of insulin resistance, a precursor to type 2 diabetes, and are associated with obesity and cardiovascular diseases. In athletes and biohackers, fasting insulin levels can be used to optimize metabolic health and improve performance by tailoring dietary and exercise interventions. However, fasting insulin levels can be influenced by various factors, including stress, recent physical activity, and medications. Therefore, it is essential to consider these confounders when interpreting results. Testing should be done in a fasting state, ideally in the morning, to ensure accuracy and comparability of results.
Klinische Bedeutung
Elevated fasting insulin levels suggest insulin resistance, which can lead to type 2 diabetes and cardiovascular diseases. Low fasting insulin levels may indicate pancreatic β-cell dysfunction or hypoglycemia.
Progressively rising fasting insulin levels suggest worsening insulin resistance. Re-test in 3 months if rising.
Falling levels may indicate improved insulin sensitivity or potential hypoglycemia.
Re-test Interval
3 months if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on medication.
Insulin levels can vary throughout the day; morning fasting levels are most reliable.
Testing Frequency
Annually for healthy adults, more frequently if managing diabetes or metabolic syndrome.
Correlated with
Current research suggests that while fasting insulin levels are associated with various psychiatric and metabolic conditions, reference ranges and optimal targets for different populations remain debated. Researchers have not yet established the impact of confounding factors such as obesity and medication on insulin resistance in diverse cohorts. Additionally, clinical questions regarding the role of fasting insulin in treatment selection for depression and its predictive value in metabolic subtypes remain unanswered.
599
Total Citations
26
Human/RCT
2.3
Avg. Influence
2025
Latest
This study examined the relationship between insulin resistance and depression. Researchers found that insulin levels and the HOMA-IR index were increased in individuals experiencing acute depression, but not during remission. Additionally, insulin resistance did not change with antidepressant treatment, suggesting a potential clinical utility for assessing insulin resistance in diagnosing metabolic subtypes of depression.
This study investigated the impact of obesity on the menstrual cycle in adolescents. Researchers found that obesity is associated with earlier onset of puberty and irregular menstrual cycles, as well as increased fasting insulin levels. The study highlights the hormonal changes linked to obesity that may affect menstrual health.
This systematic review examined the relationship between type 2 diabetes and white matter hyperintensities in the brain. Researchers found that insulin resistance and fasting insulin levels were significantly associated with the presence of white matter hyperintensities, suggesting that metabolic factors may contribute to cognitive decline in diabetes.
Wu Xuerui, et al. · The Journal of clinical endocrinology and metabolism · 2022
This study explored the association between serum thrombospondin-2 levels and metabolic syndrome severity. Researchers found that elevated thrombospondin-2 levels correlated with increased fasting insulin and other metabolic parameters. The study suggested that thrombospondin-2 could serve as a noninvasive biomarker for identifying at-risk metabolic conditions.
Key findings
This study investigated the association between insulin resistance and fibromyalgia. Researchers found that patients with fibromyalgia exhibited significant insulin resistance, as indicated by elevated HbA1c and other markers, suggesting a potential link between metabolic dysfunction and chronic pain conditions.
This study explored the effects of tirzepatide on insulin sensitivity and β-cell function in individuals with type 2 diabetes. Researchers found that tirzepatide significantly improved markers of insulin sensitivity compared to semaglutide, with greater reductions in HOMA2-IR and increases in HOMA2-B. The findings suggest that tirzepatide may be more effective in managing insulin resistance in type 2 diabetes.
This study explored the effects of L-homoarginine supplementation on blood glucose levels in obese mice. Researchers found that supplementation significantly reduced blood glucose levels and affected fasting insulin concentrations, indicating a potential link between hArg levels and metabolic parameters in obesity.
Researchers observed that individuals with diabetes and periodontitis had lower adiponectin levels compared to those with periodontitis alone. The study indicates that chronic hyperglycemia may alter adipocytokine levels, affecting inflammation and metabolic health.
Researchers summarized the effects of nutritional interventions on women with polycystic ovary syndrome (PCOS). They found that certain dietary modifications and supplements significantly reduced fasting insulin levels and improved metabolic outcomes, although high-certainty evidence for dietary changes alone was lacking.
This narrative review examined the role of gut microbiota in insulin resistance. Researchers found that gut dysbiosis affects fasting insulin levels and insulin sensitivity through various metabolites. The study suggests that microbiota-targeted strategies could potentially modulate metabolic pathways related to insulin resistance.
Research publications about Nüchterninsulin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer